MedTrace Logo

Graftless Maxillary Sinus Augmentation With CGF Utilizing DIVA System

NCT02985645 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-12-08

No results posted yet for this study

Summary

This study is intended to evaluate the efficiency of graftless maxillary sinus augmentation with concentrated growth factor (CGF) utilizing "dynamic implant valve approach" (DIVA) system.

Conditions

  • Alveolar Bone Loss

Interventions

PROCEDURE

maxillary sinus augmentation with CGF

Graftless maxillary sinus augmentation surgery with CGF application utilizing DIVA system

DEVICE

"dynamic implant valve approach" - DIVA system

The DIVA system will be used to apply the CGF to the maxillary sinus.

Sponsors & Collaborators

  • Western Galilee Hospital-Nahariya

    lead OTHER_GOV

Principal Investigators

  • Samer Srouji, Prof. · Western Galilee Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02985645 on ClinicalTrials.gov